Tiziana Life Sciences Ltd

TLSA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.80

-$0.10 (-11.57%)

At close: Oct 30, 2026, 4:00 PM ET

$0.84

+$0.04 (+4.42%)

Pre-market: Nov 2, 2026, 9:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $101.81M

Enterprise Value $99.56M

Beta 0.44

Average Volume 632.24K

Shares Outstanding (Diluted) 63.94M

Shares Change YoY 24.03%

Institutional Ownership 4.10%

Exchange NASDAQ

ISIN BMG889121031

Price Performance

Price Change 1M -27.9%

Price Change 3M -22.3%

Price Change 6M -40.3%

Price Change YTD -46.3%

Price Change 1Y -58.3%

Price Change 3Y 22.3%

Price Change 5Y -48.7%

1M CAGR (ann.) -11.7%

1Y CAGR (ann.) -57.7%

5Y CAGR (ann.) -11.9%

All-Time CAGR -18.8%

Valuation

PE Ratio -1.90

Forward PE N/A

PEG Ratio 0.06

Forward PEG -0.60

PS Ratio N/A

Forward PS N/A

PB Ratio -37.06

P/FCF Ratio -7.57

P/Adj. FCF Ratio -7.57

P/OCF Ratio -8.00

EV/Sales N/A

EV/EBIT -4.19

EV/EBITDA -4.25

EV/FCF -7.40

Earnings Yield -52.5%

FCF Yield -13.2%

Adj. FCF Yield -13.2%

Financial Health

Net Cash $3.07M

Total Debt $932K

Cash & Short-Term Investments $3.18M

Total Assets $11.66M

Current Ratio 0.69

Quick Ratio 0.69

Debt / Equity Ratio -0.34

Debt / EBITDA -0.04

Debt / FCF -0.07

OCF / Debt -14.36

Interest Coverage 0.00

Altman Z-Score -9.73

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -216.0%

Return on Equity 1869.1%

Return on Invested Capital 1284.8%

Return on Capital Employed 1214.0%

Return on Tangible Assets -216.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -63.6%

EPS CAGR 3Y 144.0%

EPS CAGR 5Y -1.4%

EPS CAGR 10Y 33.8%

FCF CAGR 3Y 4.5%

FCF CAGR 5Y -12.5%

FCF CAGR 10Y -24.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 18.3%

Revenue Growth Next 3Y N/A

Earnings Date Oct 16, 2026

EPS Estimate (next Q) -$0.08

EPS Growth Est (next Q) -18.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7.00

Price Target Upside 775.0%

Cash Flow

Operating Cash Flow $-13.38M

Free Cash Flow $-13.46M

Adj. Free Cash Flow $-13.46M

FCF Per Share -$0.11

OCF Per Share -$0.10

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-304K

Operating Income $-23.75M

EBITDA $-23.45M

Net Income $-25.19M

EPS (Diluted) -$0.42

Revenue / Employee N/A

Profit / Employee $-2.52M

Employees 10